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Background: Fasting is a rigorous type of dietary restriction that is associate with a number of health benefits.
During fasting, ketone bodies significantly increase in blood and become major body fuels, thereby sparing
glucose. In the present study, we investigated effects of fasting on hypersensitivity. In addition, we also investigated
the possible role of D-beta-hydroxybutyrate provoked by fasting in the attenuation of immediate hypersensitivity by
fasting.
Methods: Effects of fasting on systemic anaphylaxis were examined using rat model of toluene 2, 4-diisocyanate induced
nasal allergy. In addition to food restriction, a ketogenic high-fat and low-carbohydrate diet that accelerates fatty acid
oxidation and systemic instillation of D-beta-hydroxybutyrate were employed to elevate internal D-beta-hydroxybutyrate
concentration. We assessed relationship between degranulation of rat peritoneal mast cells and internal
D-beta-hydroxybutyrate concentration in each treatment. Changes in [Ca2+]i responses to compound 48/80 were
analyzed in fura 2-loaded rat peritoneal mast cells derived from the ketogenic diet and fasting.
Results: Immediate hypersensitivity reaction was significantly suppressed by fasting. A significant reduction in mast
cells degranulation, induced by mast cell activator compound 48/80, was observed in rat peritoneal mast cells
delivered from the 24 hours fasting treatment. In addition, mast cells delivered from a ketogenic diet and
D-beta-hydroxybutyrate infusion treatment also had reduced mast cell degranulation and systemic
D-beta-hydroxybutyrate concentrations were elevated to similar extent as the fasting state. The peak increase in
[Ca2+]i was significantly lower in the ketogenic diet and fasting group than that in the control diet group.
Conclusions: The results of the present study demonstrates that fasting suppress hypersensitivity reaction, and
indicate that increased level of D-beta-hydroxybutyrate by fasting plays an important role, via the stabilization of mast
cells, in suppression of hypersensitivity reaction.Background
Dietary restriction, now usually referred to as caloric re-
striction, has been known about for decades and is a very
robust intervention that produces a number of associated
health benefits and ameliorates diseases with aging [1].
Fasting is defined as voluntary food deprivation that has
been performed as religious observance for spiritual devel-
opment and promotion of health among different people
and religions worldwide [2]. Fasting have been used
mainly for the treatment of obesity [3,4], and its thera-
peutic effects have also been reported to ameliorate hyper-
tension [5], epilepsy [6], psychosomatic disease [7], and* Correspondence: vdtwork@gmail.com
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unless otherwise stated.bronchial asthma [8]. However, the mechanisms for these
benefits are still largely unknown.
During fasting, the body begins to break itself down to
supply energy and dynamic metabolic changes occur
[9,10]. At the early stage of fasting, 1-2 days after food
deprivation, hepatic glycogen and amino acids derived
from muscle began to serve as the main source for
glycogenesis for energy supply. After sources for hepatic
glycogenesis storage have been depleted, 3 days to 1 week
later, glycerol and fatty acids released from adipose tis-
sues become the major source of energy production.
Generated fatty acids are converted to acetyl-coA and
are shunted to the ketogenic pathway resulting in the
production of ketone bodies mainly in the liver. These
ketones are transported to peripheral tissues where they
can be converted back to acetyl CoA and utilized in theral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tion. In this condition, serum ketone body concentra-
tions increases approximately 1000 fold from the normal
state [11].
The beneficial pleiotropic effects of ketone bodies have
been reported other than the role of metabolic fuel. D-
beta-hydroxybutyrate (D-BHB), a major circulating ke-
tone body, has been demonstrated to be effective in
neurological disorders such as Alzheimer’s, Parkinson’s,
and Huntington’s disease in animal models and humans
[12-14]. In addition, D-BHB has been found to attenuate
corneal disorder [15,16], retinal degeneration [17], and
bone loss from ovariectomy [18]. Recent finding also
identified that D-BHB is an endogenous histone deacety-
lases inhibitor and helps cells resist oxidative stress [19].
These evidences raised the hypothesis that increased
concentrations of ketone bodies may have a possible role
in the health benefits obtained during food deprivation.
Several studies have shown that fasting enhances im-
munological defenses. Short-term fasting resulted in
lower levels of antigen-specific IgE and attenuated pul-
monary inflammation in a rat model of allergic re-
sponses to the house dust mite [20]. The Guinea pigs
sensitized with the ovalbumin reduced antigen-induced
bronchoconstriction after fasting [21].
In the present study, we investigated effects of fasting
on hypersensitivity using rat model of TDI induced nasal
allergy. In addition, we also explored the possible role of
D-BHB on the attenuation of immediate hypersensitivity
by fasting. We showed that increases in serum D-BHB
concentrations by fasting were strongly associated with
suppression of immediate hypersensitivity and mast cell




All animal experiments were performed under the fol-
lowing conditions; Room temperature 23 ± 2°C, relative
humidity 60% ± 10%, and an alternating 12-hours light–
dark cycle (8 AM to 8 PM). Animals were quarantined
and acclimatized before experiments at least for a 1-
week period standard diet (Oriental Yeast Industries,
Tokyo, Japan) and water were available ad libitum. The
care and handling of the animals were in accordance
with the National Institute of Health guidelines. All pro-
cedures involving animals were carried out in accord-
ance with the Institutional Guidelines.
Fasting
For fasting treatment, mice and rats had access to only
water. For the ketogenic diet, Diet D10070801 (Research
Diets, New Brunswick, NJ, USA), consisting of 67% fat,
17% protein, and 0% carbohydrate was used.Rat model of toluene 2, 4-diisocyanate (TDI) induced
Nasal Allergy
Nasal Allergy models were performed by the method
described previously with slight modifications [23]. Six-
week-old male Brown Norway rats (n = 6–8 in each ex-
periment) were purchased from Japan SLC, Inc. Five μl
of a 10% solution of TDI (Sigma-Aldrich, St. Louis,
MO, USA) in ethyl acetate (Sigma-Aldrich, St. Louis,
MO, USA) was intranasally applied to the bilateral
nasal cavities once a day for five consecutive days
(sensitization). This sensitization procedure was then
repeated after a 1-day interval. Seven days after the lat-
est sensitization, and prior to being evaluated, 5 μl of
10% TDI solution was applied again to the nasal cava-
ties to provoke nasal allergy-like behaviors. Sensitized
rats without provocation by TDI solution served as the
control group.
Nasal allergy-like behaviors were evaluated by counting
the amount of nasal rubbing and sneezing during a 20 mi-
nute period immediately after TDI application. Changes
in nasal secretions were evaluated by measuring the
weight of cotton thread 60 minutes after TDI application.
The total plasma IgE levels were determined after TDI
application. Blood was collected from the abdominal
aorta. Plasma samples were obtained by centrifugation
and stored at −30°C until use. The total plasma IgE level
was determined by using Rat IgE ELISA Kit (Shibayagi
Co., Ltd, Gumma, Japan) according to the manufacturers
instruction.
After nasal secretion was measured, rats were applied
to histological examination of the nasal cavity and mu-
cosa of maxilloturbinate. Rats were euthanized by cer-
vical dislocation under anesthetized with sodium
pentobarbital. The head was separated from the neck
and the whole anterior face sections were prepared using
a multipurpose cryosection preparation kit (Section Lab
Co., Ltd, Hiroshima, Japan) according to the method of
Kawamoto [24]. In brief, anterior face of tissue was fro-
zen in isopentane (−160°C) cooled with dry ice and then
freeze-embedded with SCEM compound (Section Lab
Co., Ltd, Hiroshima, Japan). Twenty-μm thick sections
were cut with cryomicrotome (CM3050S, Leica Co., Ltd,
Heidelberg, Germany) and collected with cryofilm (Sec-
tion Lab Co., Ltd, Hiroshima, Japan). For hematoxylin
and eosin (H&E) and Toluidine blue (pH4.1) staining,
tissue sections were fixed by 4% paraformaldehyde after
drying section and mounted with SCMM (Section Lab
Co., Ltd, Japan). For immunohistochemistry, the sec-
tions were incubated with a polyclonal antibody to
mast cell tryptase (Santa Cruz, CA, USA) at 4°C over-
night, followed by labeling with Alexa 488-conjugated
goat anti-rabbit IgG (Life Technologies, Inc. Grand
Island, NY, USA) and Hoechst 33342 (Dojindo Co., Ltd,
Kumamoto, Japan) at RT for 30 min. These sections
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Ltd., Tokyo, Japan) or a confocal microscope (LSM 710,
Carl Zeiss, Inc. Heidelberg, Germany).
Passive cutaneous anaphylaxis (PCA)
Six-week old male Wistar rats (Japan Clea, Inc. Tokyo,
Japan) were used (n = 7–27 in each time point). The hom-
ologous antiserum used was prepared according to the
method described. Briefly, rats were sensitized by intra-
muscular injection of 0.2 ml of 10 mg/mL egg albumin
(Sigma-Aldrich, St. Louis, MO, USA) to both femurs and
intraperitoneal administration of Bordetellapertussis in-
active microorganism suspension (B. pertussis, Kitasato
Institute Research Center for Biologicals, Saitama, Japan).
On day 14, animals were bled and antiserum was col-
lected. Separated antiserum was stored at −80°C.
Rat homologous antiserum (100 μL) was injected into
the shaved back skin of rats. After 24 h, sensitized rats
were injected with 0.5 mL of mixed solution of 0.5%
Evan blue (Fluka, Buchs, Switzerland) and 1% egg albu-
min (1:1) through the tail vein. Thirty minutes later, rats
were sacrificed and the dye content of the shaved dorsal
skin was determined quantitatively. Pieces of the dorsal
skin containing extravasated dye were removed and
soaked overnight in stoppard glass tubes containing
1 ml of mixed solution of 0.6 N H3PO4/acetone (13:5).
The absorbance of supernatant was measured at 620 nm
using a spectrophotometer and the concentration of the
dye in the shaved dorsal skin (μg/site) was determined.
Fasting duration was determined as the time between
food removal and antigen challenge.
Systemic anaphylactic shock
Ten-week old male BALB/c mice (Japan Clea, Inc.
Tokyo, Japan) were used (n = 6–12 in each experiment).
For the evaluation for IgE dependent anaphylaxis, mice
were sensitized with an intraperitoneal injection of
125 μg egg albumin dissolved in aluminum gel. Seven
days later, mice were challenged by intraperitoneal injec-
tion of 125 μg egg albumin dissolved in aluminum gel
[25]. For IgE independent anaphylaxis, anaphylactic
shock was evoked by intraperitoneal injection of 6.5 mg/
kg compound 48/80 (Sigma-Aldrich, St. Louis, MO,
USA) in saline solution [26]. Immediately after the anti-
gen or compound 48/80 challenge, rectal temperature
was measured with a digital thermometer (Tateyama
kagaku industry Co.,Ltd, Toyama, Japan).
Preparation of rat peritoneal mast cells
Eleven-week old male Sprague Dawley rats (Japan Clea,
Inc. Tokyo, Japan) were used (n = 4 in each treatment).
Rat peritoneal mast cells (RPMC) were collected by rins-
ing the peritoneal cavities of normal rats with 20 ml of
mast cell medium (MCM, containing 150 mM NaC1,3.7 mM KC1, 3.0 mM Na2HPO4, 3.5 mM KH2PO4,
5.6 mM dextrose,0.1% gelatin, 0.1% (w/v) bovine serum
albumin) containing 10 U/ml heparin under anesthesia
with pentobarbital. Peritoneal cells were sedimented
twice at 50 x G for 7 minutes at 4°C and re-suspended
in MCM. RPMC were then washed twice with siraganian
buffer [119 mM NaCl, 5 mM KCl, 0.4 mM MgCl2,
25 mM piperazine-N,N0-bis(2-ethanesulfonic acid)(PIPES),
pH 7.2] and resuspended in siraganian buffer. RPMC
(5 × 104).
Degranulation assay
The degree of degranulation was determined by measur-
ing the release of β-hexosaminidase [27]. The enzymatic
activity of β-hexosaminidase in supernatants and sonicated
disrupted cell pellets was measured with p-nitrophenyl N-
acetyl-β-d-glucosaminide (Sigma-Aldrich, St. Louis, MO,
USA) in 0.1 M sodium citrate (pH 4.5) for 60 minutes at
37°C. The reaction was stopped by the addition of 1 M
Na2CO3 glycine. The release of the product, 4-p-
nitrophenol, was detected by absorbance at 405 nm. The
extent of degranulation was calculated by dividing 4-p-
nitrophenol absorbance in the supernatant by the sum of
absorbance in the supernatant and disrupted cell pellet.
To induce RPMC degranulation, cells were incubated
with 1 μg/mL compound 48/80 at 37°C for 10 minutes.
For the evaluation of the effect of D-BHB on mast cell
degranulation, cells were preincubated with various con-
centrations of D-BHB for 10 minutes, and then incu-
bated with compound 48/80.
Measurement of intracellular calcium
The [Ca2+]i in RPMC was measured with the fluorescent
Ca2+ indicator, Fura-2/AM (Invitrogen, Carlsbad, CA,
USA). Cells were plated onto glass bottom culture dishes.
The cell was loaded with the indicator by incubation with
2.5 μM of Fura-2/AM in in Standard Solution (140 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM HEPES, 10 mM
dextrose) for 4 h at room temperature (22–24°C). After
loading, cells were washed three times with Standard solu-
tion and incubated for further 30 minutes to ensure de-
esterification. Fluorescence recordings were performed
using two set-ups, employing either video-imaging or a
single detector system. For video-imaging, a coverslip with
dye-loaded cells was mounted in a chamber fixed on the
stage of an inverted fluorescence microscope (IX71,
Olympus Co., Tokyo, Japan) equipped with UV objective
lens (UApo 20X3/340, Olympus Co., Tokyo, Japan). The
emission signal passed through a band pass filter (500 ±
10 nm) and was detected by a 12 bit CCD camera (C-
8214, Hamamatsu Photonics K.K., Hamamatsu, Japan).
Fluorescence intensities at 510 nm with excitation at 340
and 380 nm were recorded at 5 s intervals. The [Ca2+]i in
an individual cell was calculated from the ratio of
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those at 380 nm. All experiments were performed at room
temperature (22–24°C).
Increases in [Ca2+]i were evoked by 1 μg/mL com-
pound 48/80 for 240 sec. For the evaluation of the effect
of D-BHB on [Ca2+]i, cells were stimulated with com-
pound 48/80 under 100 mM D-BHB.
Serum and intraperitoneal D-BHB
Eleven-week old male Sprague Dawley rats (Japan Clea,
Inc. Tokyo, Japan) were used (n = 4 in each treatment).
The concentration of D-BHB in collected serum and intra-
peritoneal fluid was measured using Ketone test A (Sanwa
kagaku kenkyusho Co., Ltd., Nagoya, Japan) according to
the manufacturers instruction.
Statistical analysis
We used the Student’s t-test for comparison of the two
groups and the Dunnett test for multiple comparisons.Figure 1 Fasting treatment attenuates the hypersensitivity reaction in
sneezing (B), nasal secretion (C) and serum IgE concentration (D). Nasal ru
provocation. Sensitized rats without applied TDI solution served as the con
means ± SEM, n = 5-6 rats, *P < 0.05 significantly different from AL + TDI. #PThe Pearson product–moment correlation coefficient was
used to evaluate association between anaphylactic response
and changes in serum D-BHB concentration. Differences
between measured variables were considered significant if
the resultant P value was 0.05 or less. Analysis was per-
formed using the JMP version 8 (SAS Institute Inc., Cary,
North Carolina, USA).Results
Fasting treatment attenuates the nasal hypersensitivity
reaction in TDI-sensitized nasal allergy model rat
Figure 1 shows changes in allergy-like behaviors, nasal
rubbing (A), sneezing (B), and nasal secretion (C) and
serum IgE concentration (D) induced by 24 hours fast-
ing. For the food and water Ad libitium group (AL), TDI
application induced significant increases in each allergy
behavior compared to control group. For the 24 hours
fasting group, TDI application induced increases in eachTDI-sensitized nasal allergy model rat. Nasal rubbing (A), nasal
bbing and sneezing were measured for 20 minutes immediately after
trol group. Non-sensitized rats served as the normal group. Values are
< 0.05, ##P < 0.001 significantly different from control or normal group.
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lower than that of AL + TDI group.
Corresponding to previous measurements of sensitization
with TDI [28,29], total serum IgE concentration was signifi-
cantly higher in AL with TDI group than in the normal
value. For the fasting with TDI group, significant increases
were observed than the normal value. Though, no signifi-
cant difference was observed between AL with TDI group
and fasting with TDI group.
Figure 2 shows mucus secretion and mast cell alter-
ation in the nasal cavity and mucosa of maxilloturbinate.
The mucus secretion in the nasal cavity and epithelia
was increased in the AL with TDI group compared to
control group. In the 24 hours fasting group with TDI,
these mucus secretion were maintained as same level as
control group (Figure 2 upper).
The mast cells presented in lamina propria of nasal
epithelia were non-degranulated in the control group. In
the AL with TDI group, mast cells were degranulated.
Twenty four hours fasting with TDI maintained the mast
cells non-degranulated (Figure 2 middle).Figure 2 Representative photomicrographs of the distal end of the m
Hematoxylin and eosin stainig (Upper). The mucus secretion in the nasal ca
staining (Middle). The degranulated mast cells presented in lamina propria
images of mast cell. Immunohistochemical detection of mast cell tryptase
non-degranulated mast cell. Arrow head: degranulated mast cell.The content of tryptase in the mast cells was apparent in
the control group than AL withTDI group. In the 24 hours
fasting group with TDI, mast cell tryptase were maintained
as same level as control group (Figure 2 lower). These
histological observations support the results of suppressed
nasal hypersensitivity reaction by the fasting.
Fasting treatment attenuates systemic anaphylaxis
To examine the effect of food restriction on systemic ana-
phylaxis, we evaluated antigen or compound 48/80 induced
anaphylactic responses in immediate type hypersensitivity
by reductions in rectal temperature. For the 24 hours
fasting group, reductions in rectal temperature were
significantly smaller than those of the AL group in both
antigen and compound 48/80 induced anaphylaxis
models (Figures 3A and B).
Suppression of the PCA reaction correlates with fasting
duration and serum D-BHB concentrations
It has been known that fasting markedly increases circu-
lating concentrations of D-BHB [11]. To investigate theaxilloturbinate in TDI-sensitized nasal allergy model rat.
vity and epithelia was increased in the AL with TDI. Toluidine blue
of nasal epithelia in the AL with TDI. Insets show the magnified
(Lower). Tb: turbinate bone. C: nasal cavity E: nasal epithelium. Arrow:
Figure 3 Fasting treatment attenuates the hypersensitivity reaction in systemic anaphylaxis models. Antigen induced IgE-dependent
model (A). Ig-E independent model by interperitoneal injection of compound 48/80 (B). Rectal temperature was recorded after antigen or compound
48/80 provocation. Values are means ± SEM, n = 6-12 mice. *P < 0.05 significantly different from AL.
Figure 4 Suppression of the PCA reaction correlate with fasting duration and serum D-BHB concentrations. Evans blue dye (EVD) leakage
(A), Typical photographs of the PCA reaction (B), Bar: 10 mm Serum D-BHB concentration (C). Values are means ± SEM, n = 7-27 rats. *P< 0.05 significantly
different from ad libitium (AL). Correlation between EVD leakage and D-BHB concentrations (D). n = 87 rats. Fasting duration was determined as the time
between food removal and antigen challenge.
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in serum D-BHB concentrations by food restriction, we
quantitatively analyzed the anaphylactic response using
the PCA reaction. In rats during fasting, PCA was reduced
in a time-dependent manner and significant reductions
were observed after 12 hours starvation (Figures 4A and B).
In contrast to the PCA reaction, serum D-BHB concentra-
tions increased in a time dependent manner and significant
increases were observed after 12 hours fasting (Figure 4C).
This result almost corresponds to a previous report [30]. A
significant correlation between individual PCA and D-BHB
concentrations was observed during the fasting period
(Figure 4D).
Relationship between changes in systemic D-BHB
concentrations and inhibition of mast cell degranulation
Degranulation of mast cells plays a crucial role in the
pathogenesis of anaphylaxis and allergic disorders [22].
Two methods were used to compare the effect of ele-
vated systemic D-BHB and mast cell degranulation with
fasting; a ketogenic diet, which accelerates fatty acid oxi-
dation; and systemic instillation of D-BHB.
For fasting, significantly (approximately ten-fold) higher
serum and intraperitoneal D-BHB concentrations were ob-
served 15 and 24 hours after food restriction than that be-
fore food restriction. The elevated D-BHB concentrations
returned to pre food deprivation values 3 hours after
refeeding with the control diet (Figure 5 upper middle).Figure 5 Correlation between changes in systemic D-BHB concentrati
concentration (Left), Intraperitoneal D-BHB concentration (Middle) and Inhib
(Middle) and Subcutaneous D-BHB instillation (Lower). Values are means ± SEM
***P < 0.005 significantly different from initial values.Corresponding to changes in D-BHB concentrations,
mast cell degranulation to compound 48/80 was inhib-
ited 15 and 24 hours after food restriction and returned
to pre food deprivation ratios 3 hours after the refeeding
period (Figure 5 upper right).
For the ketogenic diet, significantly (approximately
eight-fold) higher serum and intraperitoneal D-BHB
concentrations were observed 15 and 24 hours after food
feeding of the ketogenic diet than that before feeding of
the ketogenic diet (Figure 5 middle left and middle cen-
ter). These values were almost the same as values mea-
sured with the fasting treatment. Elevated D-BHB
concentrations returned to pre ketogenic diet values
3 hours after refeeding with the control diet. Corre-
sponding to fasting and changes in D-BHB concentra-
tion, mast cell degranulation to compound 48/80 were
significantly inhibited after 15 and 24 hours after food
restriction and retuned to before ketogenic diet ratio
3 hours after re-feeding (Figure 4 middle right).
For intradermal infusion of D-BHB, significant increases
in serum and intraperitoneal D-BHB concentrations were
observed immediately after infusion, which then gradually
decreased (Figures 5 lower left and lower center). Serum
D-BHB returned to initial levels after 3 hours. Intraperito-
neal D-BHB concentrations remained at approximately
half the value of the maximal concentrations after 3 hours
infusion. Mast cell degranulation was significantly inhibited
after D-BHB infusion and the inhibition rate plateaued 1ons and inhibition of mast cell degranulation. Serum D-BHB
ition of mast cell degranulation (Right). Fasting (Upper), Ketogenic diet
, n = 4 rats. CD: control diet. KD: ketogenic diet. *P < 0.05, **P < 0.01,
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3 hours after infusion (Figure 5 lower right).
Fasting and D-BHB suppresses mast cell degranulation
and intracellular calcium oscillations by compound 48/80
Changes in [Ca2+]i responses to compound 48/80 were
analyzed in fura 2-loaded RPMC derived from the keto-
genic diet, fasting, and in vitro exposure to 100 mM D-
BHB.
Compound 48/80 evoked increases in [Ca2+]i upon a
240 seconds application and these responses were revers-
ible. Compare to RPMC The [Ca2+]i response to com-
pound 48/80 was lower in RPMC derived from the
ketogenic diet and fasting group than RPMC derived
from free access to the control diet. The amplitude of
the [Ca2+]i increase in fasting was similar to that ob-
tained with the ketogenic diet (Figure 6A). The peak in-
crease in [Ca2+]i from baseline (Δ[Ca
2+]i) was significantly
lower in the ketogenic diet and fasting group than that in
the control diet group (Figure 6B).
To confirm the effect of D-BHB, we incubated D-BHB
with isolated mast cell in vitro. D-BHB inhibited mast cellFigure 6 Fasting and D-BHB suppress the RPMC [Ca2+]i mobilization r
mast cells from fasting and the ketogenic diet (A). Values represent means (n =
48/80 (B). RPMC prepared form each treatment were stimulated with 1 μg/mL
*P< 0.05 significantly different from ad libitium (AL). The effect of D-BHB o
concentrations of D-BHB for 10 minutes, and then incubated (10 minutes
Time courses for [Ca2+]i responses of mast cells treated with D-BHB (D). V
images of non-treatment (a) and D-BHB treatment (b) mast cells activate
response to compound 48/80 (F). Cells were stimulated with 1 μg/mL co
means ± SEM, n = 6, * P < 0.05 significantly different from non-treatment (degranulation in a dose dependent manner (Figure 6C).
Significant inhibition was observed at more than 10 mM
(Figures 6D and E). In addition, pretreatment with D-BHB
decreased compound 48/80 evoked [Ca2+]i and Δ[Ca
2+]i
was significantly suppressed (Figure 6F).
Discussion
The present study clearly demonstrated that food
deprivation attenuated local and systemic immediate
hypersensitivity symptoms. This attenuation was signifi-
cantly correlated with the duration of food restriction
and increases in blood D-BHB concentrations (Figures 4
and 5). Type I allergy is an immediate hypersensitivity
reaction that is characterized by allergen-induced mast
cell degranulation and is followed by the immediate re-
lease of the chemical mediator histamine from mast cells
stored in vesicles, which leads to inflammation, smooth
muscle contraction, and vasodilation reaction [31]. In
the present study, fasting did not affect serum IgE con-
centration (Figure 1C). D-BHB is an abundant ketone
body normally circulating in the blood, but an antihista-
mine effect or antagonistic action to immune reactiveesponse to compound 48/80. Time courses for [Ca2+]i responses of
12 aciner cells). Comparison of [Ca2+] i changes in response to compound
compound 48/80 for 240 sec. Values are means ± SEM, n = 12 aciner cells,
n mast cell degranulation (C). Cells were preincubated with various
) with 1 μg/mL compound 48/80. Values are means ± SEM, n = 6 rats.
alues represent means (n = 12 aciner cells). E: Pseudo color [Ca2+]i
d by compound 48/80. The effect of D-BHB on [Ca2+]i changes in
mpound 48/80 for 240 sec under 100 mM D-BHB. Values are
NT).
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fore, to further investigate the relationship between D-
BHB and allergic reactions, we focused on the effect of
D-BHB on mast cell activation.
It has been reported that, the restriction of nutrition
supplementation creates various enhancing effect on the
cell mediated defense. To exclude the possible defense
response by food deprivation other than increased D-
BHB, we employed two methods to elevate internal D-
BHB concentration in addition to fasting; a ketogenic
high-fat, adequate-protein, and low-carbohydrate diet
that accelerates fatty acid oxidation [32] and systemic in-
stillation of D-BHB. Our results showed that, both treat-
ments dramatically increased blood and intraperitoneal
D-BHB concentrations similar to fasting and this was ac-
companied by inhibition of mast cell degranulation in-
duced by compound 48/80 (Figure 5). The inhibitory
effect of mast cell degranulation by each treatment was
diminished after D-BHB concentrations returned to a
normal state by the interruption of each diet and D-BHB
infusion. From these observations, we speculated that
endogenous D-BHB which was dramatically increased by
food deprivation, plays an important role in the attenu-
ation of hypersensitivity symptoms through suppression
of mast cell activation.
Increases in intracellular calcium activity are critical for
the rapid exocytotic response of mast cells. The signaling
pathway leading to exocytosis of mast cells has been well
characterized [33]. Interestingly, mast cells delivered from
24 hours of food deprivation and a ketogenic diet showed
a decrease in mast cell [Ca2+]i mobilization induced by ex-
posure to compound 48/80. Furthermore, in vitro D-BHB
treatment with mast cells delivered from a control diet rat
also suppressed degranulation and [Ca2+]i mobilization
(Figure 4). G protein coupled receptor-mediated activation
of phospholipase C and the associated production of inosi-
tol 1,4,5-trisphosphate induces release of Ca2+ from stores
in the endoplasmic reticulum and Golgi apparatus through
Ca2+-conducting IP3-receptors. Compound 48/80 is also
known to initiate mast cell degranulation through direct
activation of G proteins, which was proposed to mimic re-
ceptor signaling [34,35]. Thus, we speculate that D-BHB
might have inhibited downstream of G-protein coupled
intracellular signaling pathway, which leads to stabilization
of mast cell membranes against degranulation stimuli. Fur-
ther study is necessary to determine the cellular and mo-
lecular mechanism(s) underlying the stabilization of mast
cells by D-BHB.
During a fasting state, D-BHB is synthesized in the liver
from acetyl-CoA mostly derived from beta-oxidation of fatty
acids. The rate limiting step of D-BHB formation is mito-
chondrial hydroxymethylglutaryl-CoA synthase (mHMG-
CoAS), which converts acetoacetyl-CoA and acetyl-CoA into
3-hydroxy-3-methylglutaryl-CoA [36]. The enzymatic activityof HMG-CoAS is elevated by deacetylation by sirtuin-3
(Sitrt3) [37]. Also, the mammalian target of the rapamycin
(mTOR) signal controls D-BHB formation during fasting by
modulating peroxisome proliferator-activated receptor medi-
ated activation of the mHMG-CoAS enzyme [38]. Sirt3 and
mTOR are known as key regulators of energy metabolic
homeostasis during fasting and calorie restriction [39,40],
which has been linked to ameliorate diseases associate with
aging [41,42]. Several studies have shown that calorie restric-
tion can mitigate excessive immune response [43-46], but
the mechanisms for this attenuation are still largely un-
known. Prolonged restriction of calorie intake also leads to
higher serum D-BHB concentrations [47-49]. Altogether, our
findings with the pleiotropic property of D-BHB were able to
rule out the possibility that D-BHB is not the only alternative
energy source that spares glucose, but is one of the defense
molecules that participates in a number of health benefits
during dietary restriction.
Conclusion
We demonstrated that fasting attenuated immediate hyper-
sensitivity symptoms. In addition, we provided evidence
that D-BHB generated by fasting plays an important role
for the sedate excess immune response against immediate
hypersensitivity. We believe further investigations focused
on the role of ketone bodies in immunological function will
pave the way to understanding the molecular mechanisms
for the positive health benefits of fasting.
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